My cousin can’t eat due to severe gastroparesis. She’s lost ~30% of her weight, is mostly bedridden and relies on IV hydration. Mayo Clinic may help, but Medicaid linked insurance denies her and won’t allow self-pay. #NeedDirection #Gastroenterology #Livertwitter

New global consensus on MASLD highlights weight loss, Mediterranean diet, and physical activity as pillars of treatment. A ≥10% weight reduction shows greatest benefit in fibrosis regression. #MASLD #LiverHealth

👉 This October, I’m asking: screen earlier. screen often. Early detection = more survivors. Awareness saves lives. Action saves more. #LiverCancerAwareness #LiverCancerSurvivor #LiverAwareness #LiverTransplant #Octoberis4Livers

As a transplant patient I have to laugh..

My husband bought me this for out anniversary. #Jeep

This day of recognition is dedicated to raising awareness of transplantation as a vital treatment option and it also calls for greater support, education, and timely access for everyone impacted by advanced lung disease.

#ColoradoSprings to see my daughter. Thankful my donor gave me this opportunity. #LiverTransplant #LiverCancer #Octoberis4Livers

October is for Livers 💚 The signs of liver disease are easy to miss but when they show up together, pay attention. Fatigue. Itchy skin. Yellow eyes. Swelling. Brain fog. Loss of appetite. Your liver is talking. #OctoberIs4Livers #LiverDisease #KnowTheSigns #EndTheStigma 💚

My liver dressed up for Halloween Elliot Tapper #Livertwitter AASLD AJG - The American Journal of Gastroenterology

Since a 2018 liver transplant for her inoperable cancer, Lorrinda Gray-Davis has devoted herself to organ transplant advocacy and outreach. Read her inspiring Cancer Today story during #LiverCancerAwarenessMonth: brnw.ch/21wWMbS

Food insecurity increases the risk of: 1. Liver disease incidence 2. Liver disease severity 3. Liver disease mortality journals.lww.com/hepcomm/fullte….

Finished this today. 🎉

Ammonia levels get the spotlight, but confusion steals the scene. Overt? Nah, for patients, it’s Covert.

The prognosis of liver disease depends on the extent of fibrosis, which is usually staged with the use of liver biopsy. The limitations of biopsy have led to the development of noninvasive tests, which Drs. Laurent Castera, Mary E. Rinella, and Emmanuel A. Tsochatzis review.

Headed to #TLM25? Come join me in D.C.! 💚 AASLD #LiverTwitter I’ll be moderating two sessions Fri 11/7 | 11:00 AM – 12:30 PM Mapping the Transplant Journey Fri 11/7 | 4:00 PM – 5:30 PM Breaking Barriers Can’t wait to see everyone at #TLM25 #LiverDisease

Honored to have a Poster of Distinction at AASLD #TLM25! 💚 How the Cause of Liver Failure Shapes the Post-Transplant Journey: Patient-Reported Outcomes Across Etiologic Categories 2159 🗓️ Sat Nov 8 | 8–5 ET | Hall DE #LiverDisease #TransplantCommunity #LiverTwitter

This trial speaks to me

Non-invasive assessment of liver fibrosis - 🆕 review in NEJM 💡 1️⃣ Algorithm 2️⃣ Diagnosis and staging of liver fibrosis 3️⃣ Summary of non-invasive tests 📸: nejm.org/doi/full/10.10…

Heading to AASLD inaugural #HarrisonFellow looking forward to learning and community. #LiverRecipient #LiverDisease